» Articles » PMID: 26911151

Magnetic Resonance Analysis of Malignant Transformation in Recurrent Glioma

Overview
Journal Neuro Oncol
Specialties Neurology
Oncology
Date 2016 Feb 26
PMID 26911151
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Patients with low-grade glioma (LGG) have a relatively long survival, and a balance is often struck between treating the tumor and impacting quality of life. While lesions may remain stable for many years, they may also undergo malignant transformation (MT) at the time of recurrence and require more aggressive intervention. Here we report on a state-of-the-art multiparametric MRI study of patients with recurrent LGG.

Methods: One hundred and eleven patients previously diagnosed with LGG were scanned at either 1.5 T or 3 T MR at the time of recurrence. Volumetric and intensity parameters were estimated from anatomic, diffusion, perfusion, and metabolic MR data. Direct comparisons of histopathological markers from image-guided tissue samples with metrics derived from the corresponding locations on the in vivo images were made. A bioinformatics approach was applied to visualize and interpret these results, which included imaging heatmaps and network analysis. Multivariate linear-regression modeling was utilized for predicting transformation.

Results: Many advanced imaging parameters were found to be significantly different for patients with tumors that had undergone MT versus those that had not. Imaging metrics calculated at the tissue sample locations highlighted the distinct biological significance of the imaging and the heterogeneity present in recurrent LGG, while multivariate modeling yielded a 76.04% accuracy in predicting MT.

Conclusions: The acquisition and quantitative analysis of such multiparametric MR data may ultimately allow for improved clinical assessment and treatment stratification for patients with recurrent LGG.

Citing Articles

Exploring adult glioma through MRI: A review of publicly available datasets to guide efficient image analysis.

Abbad Andaloussi M, Maser R, Hertel F, Lamoline F, Husch A Neurooncol Adv. 2025; 7(1):vdae197.

PMID: 39877749 PMC: 11773385. DOI: 10.1093/noajnl/vdae197.


Congress of Neurological Surgeons systematic review and evidence‑based guidelines on the management of recurrent diffuse low-grade glioma: update.

Morrow K, Sloan A, Olson J, Ormond D J Neurooncol. 2024; 171(1):105-130.

PMID: 39400661 DOI: 10.1007/s11060-024-04838-5.


A patient-derived cell model for malignant transformation in IDH-mutant glioma.

Kim O, Sergi Z, Yu G, Yamamoto K, Quezado M, Abdullaev Z Acta Neuropathol Commun. 2024; 12(1):148.

PMID: 39256867 PMC: 11385154. DOI: 10.1186/s40478-024-01860-6.


A single-institution retrospective analysis of pathologically determined malignant transformation in mutant glioma patients.

Liu V, Wetzel E, Eldred B, Zapanta Rinonos S, Prins T, Khanlou N Neurooncol Adv. 2023; 5(1):vdad036.

PMID: 37152809 PMC: 10162112. DOI: 10.1093/noajnl/vdad036.


Analysis of Clinical Characteristics and Risk Factors of Postoperative Recurrence and Malignant Transformation of Low-Grade Glioma.

Luo C, Luo Q, Xu Y, Song J, Liu Y, Wang L J Oncol. 2022; 2022:4948943.

PMID: 36090892 PMC: 9452933. DOI: 10.1155/2022/4948943.


References
1.
Crane J, Olson M, Nelson S . SIVIC: Open-Source, Standards-Based Software for DICOM MR Spectroscopy Workflows. Int J Biomed Imaging. 2013; 2013:169526. PMC: 3732592. DOI: 10.1155/2013/169526. View

2.
Riemenschneider M, Reifenberger G . Molecular neuropathology of low-grade gliomas and its clinical impact. Adv Tech Stand Neurosurg. 2010; 35:35-64. DOI: 10.1007/978-3-211-99481-8_2. View

3.
Park I, Chen A, Zierhut M, Ozturk-Isik E, Vigneron D, Nelson S . Implementation of 3 T lactate-edited 3D 1H MR spectroscopic imaging with flyback echo-planar readout for gliomas patients. Ann Biomed Eng. 2010; 39(1):193-204. PMC: 3010202. DOI: 10.1007/s10439-010-0128-x. View

4.
Lupo J, Cha S, Chang S, Nelson S . Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. AJNR Am J Neuroradiol. 2005; 26(6):1446-54. PMC: 8149056. View

5.
Shannon P, Markiel A, Ozier O, Baliga N, Wang J, Ramage D . Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003; 13(11):2498-504. PMC: 403769. DOI: 10.1101/gr.1239303. View